Lili Mao

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring <i>c-Kit</i> Mutation or Amplification

Jun Guo, Lu Si, Yan Kong et al. · Journal of Clinical Oncology · 2011 · 673 citations · Full text

Large-Scale Analysis of <i>KIT</i> Aberrations in Chinese Patients with Melanoma

Yan Kong, Lu Si, Yanyan Zhu et al. · Clinical Cancer Research · 2011 · 251 citations

The Placental Microbiome Varies in Association with Low Birth Weight in Full-Term Neonates

Jia Zheng, Xinhua Xiao, Qian Zhang et al. · Nutrients · 2015 · 194 citations · Full text

Phase II Randomized Trial Comparing High-Dose IFN-α2b with Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

Bin Lian, Lu Si, Chuanliang Cui et al. · Clinical Cancer Research · 2013 · 193 citations

Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients

Bixia Tang, Xieqiao Yan, Xinan Sheng et al. · Journal of Hematology & Oncology · 2019 · 185 citations · Full text